News

Chinese efforts to reduce drug prices may trigger competitive market share shake-up

Firms that rely on low-quality drugs could drop out of the industry.

India's pharmaceutical market could hit $32.2b by 2023

Patient demand and chronic therapies continue to be growth drivers for the sector.

Singapore healthcare professionals to enjoy 5-10% pay hikes

Those in the diagnostics and devices sectors can enjoy the highest wage increase.

Malaysia's medical device industry may suffer on reluctance to sign the CPTPP free trade agreement

Its 2018 medical device investments of $160.2m paled in compariston to 2017’s $500m.

OUE Lippo Healthcare to expand network to Myanmar with $19.5m acquisition

It bought stakes in two joint venture companies with three hospitals, one medical centre and two clinics.

Medicine consumption in Australia to grow to AU$15.8b by 2022: Fitch

The country will remain one of the most attractive markets globally.

Australian health group Healius rejects $1.43b takeover proposal by Jangho Hong Kong

The Jangho Group holds 15.93% of the issued share capital of Healius.

Tax reliefs for insurance policies and new mothers may benefit Singapore's economy

Deductions could be subject to a cap which could be scaled according to age.

Healthcare boosted Singapore's capital markets in 2018

Four healthcare firms made their trading debut on SGX’s Catalist board.

OUE Lippo Healthcare to manage three Chinese medical facilities

It will expand its healthcare network into Shanghai, Chongqing and Nanjing.

7 in 10 Singapore women worry about affordable healthcare after retirement

2 in 5 of them are either not checking how much they've put in for retirement or have no contributions at all.

Malaysia proposes 7.8% larger 2019 budget of US$6.9b for healthcare

It will allocate $8.4m of its healthcare budget to boost Malaysia’s image as a health tourism destination.

OUE Lippo Healthcare inks deal to develop high-end international hospital in Shenzhen

The hospital will have more than 200 beds serving the local community.

China's push for bulk medicine purchases a big no-no for pharmaceutical firms

Chinese drug stocks fell due to investor concerns on the average -52% drop in generic drug prices.